Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

SU-G-TeP3-03: Dose Enhancement of Gold Nanoparticle in Proton Therapy: A Monte Carlo Study Based On the Transmission Electron Microscopy Imaging.

Ma Y, Laprise-Pelletier M, Lagueux J, Cote M, Fordin M, Beaulieu L.

Med Phys. 2016 Jun;43(6):3674. doi: 10.1118/1.4957083.

PMID:
28047656
2.

Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer.

Halpern JA, Sedrakyan A, Hsu WC, Mao J, Daskivich TJ, Nguyen PL, Golden EB, Kang J, Hu JC.

Cancer. 2016 Aug 15;122(16):2496-504. doi: 10.1002/cncr.30101.

PMID:
27224858
3.

Quality of Life in Women Undergoing Breast Irradiation in a Randomized, Controlled Clinical Trial Evaluating Different Tumor Bed Boost Fractionations.

Finkel MA, Cooper BT, Li X, Fenton-Kerimian M, Goldberg JD, Formenti SC.

Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):579-89. doi: 10.1016/j.ijrobp.2016.02.004.

PMID:
27045811
4.

[Localized prostate cancer: Radiotherapeutic concepts].

Grimm M, Wenz F.

Urologe A. 2016 Mar;55(3):326-32. doi: 10.1007/s00120-016-0042-4. Review. German.

PMID:
26895435
5.

A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.

Fang P, Mick R, Deville C, Both S, Bekelman JE, Christodouleas JP, Guzzo TJ, Tochner Z, Hahn SM, Vapiwala N.

Cancer. 2015 Apr 1;121(7):1118-27. doi: 10.1002/cncr.29148.

6.

Proton beam therapy for the treatment of prostate cancer.

Pugh TJ, Lee AK.

Cancer J. 2014 Nov-Dec;20(6):415-20. doi: 10.1097/PPO.0000000000000083. Review.

PMID:
25415688
7.

Progress and controversies: Radiation therapy for prostate cancer.

Martin NE, D'Amico AV.

CA Cancer J Clin. 2014 Nov-Dec;64(6):389-407. doi: 10.3322/caac.21250. Review.

8.

Results and DVH analysis of late rectal bleeding in patients treated with 3D-CRT or IMRT for localized prostate cancer.

Someya M, Hori M, Tateoka K, Nakata K, Takagi M, Saito M, Hirokawa N, Hareyama M, Sakata K.

J Radiat Res. 2015 Jan;56(1):122-7. doi: 10.1093/jrr/rru080.

9.

Systematic review of the cost effectiveness of radiation therapy for prostate cancer from 2003 to 2013.

Amin NP, Sher DJ, Konski AA.

Appl Health Econ Health Policy. 2014 Aug;12(4):391-408. doi: 10.1007/s40258-014-0106-9. Review.

PMID:
25022451
11.

Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique.

Habl G, Hatiboglu G, Edler L, Uhl M, Krause S, Roethke M, Schlemmer HP, Hadaschik B, Debus J, Herfarth K.

BMC Cancer. 2014 Mar 19;14:202. doi: 10.1186/1471-2407-14-202.

12.

Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.

Georg D, Hopfgartner J, Gòra J, Kuess P, Kragl G, Berger D, Hegazy N, Goldner G, Georg P.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):715-22. doi: 10.1016/j.ijrobp.2013.11.241.

PMID:
24521685
13.

Impact of national guidelines on brachytherapy monotherapy practice patterns for prostate cancer.

Tseng YD, Paciorek AT, Martin NE, D'Amico AV, Cooperberg MR, Nguyen PL.

Cancer. 2014 Mar 15;120(6):824-32. doi: 10.1002/cncr.28492.

14.

Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer.

Pugh TJ, Munsell MF, Choi S, Nguyen QN, Mathai B, Zhu XR, Sahoo N, Gillin M, Johnson JL, Amos RA, Dong L, Mahmood U, Kuban DA, Frank SJ, Hoffman KE, McGuire SE, Lee AK.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):946-53. doi: 10.1016/j.ijrobp.2013.08.032.

15.
16.

Evolution of advanced technologies in prostate cancer radiotherapy.

Zaorsky NG, Harrison AS, Trabulsi EJ, Gomella LG, Showalter TN, Hurwitz MD, Dicker AP, Den RB.

Nat Rev Urol. 2013 Oct;10(10):565-79. doi: 10.1038/nrurol.2013.185. Review.

PMID:
24018567
17.

MR imaging of prostate cancer in radiation oncology: what radiologists need to know.

Boonsirikamchai P, Choi S, Frank SJ, Ma J, Elsayes KM, Kaur H, Choi H.

Radiographics. 2013 May;33(3):741-61. doi: 10.1148/rg.333125041.

PMID:
23674772
18.

Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions.

Zeng C, Giantsoudi D, Grassberger C, Goldberg S, Niemierko A, Paganetti H, Efstathiou JA, Trofimov A.

Med Phys. 2013 May;40(5):051708. doi: 10.1118/1.4801897.

19.

Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma.

Candela-Juan C, Perez-Calatayud J, Ballester F, Rivard MJ.

Med Phys. 2013 Mar;40(3):033901. doi: 10.1118/1.4791647.

PMID:
23464344
20.

Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.

Gray PJ, Paly JJ, Yeap BY, Sanda MG, Sandler HM, Michalski JM, Talcott JA, Coen JJ, Hamstra DA, Shipley WU, Hahn SM, Zietman AL, Bekelman JE, Efstathiou JA.

Cancer. 2013 May 1;119(9):1729-35. doi: 10.1002/cncr.27956.

Items per page

Supplemental Content

Loading ...
Support Center